Management of people with haemophilia A undergoing surgery while receiving emicizumab prophylaxis: Real‐world experience from a large comprehensive treatment centre in the US

INTRODUCTION: Surgery is frequently required in persons with haemophilia A (PwHA). Emicizumab, a bispecific, humanized monoclonal antibody, bridges activated factor (F) IX and FX. Management of patients undergoing surgery while receiving emicizumab is of clinical interest due to paucity of data. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewandowska, Magdalena, Randall, Nicole, Bakeer, Nihal, Maahs, Jennifer, Sagar, Jeanne, Greist, Anne, Shapiro, Amy D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898816/
https://www.ncbi.nlm.nih.gov/pubmed/33245841
http://dx.doi.org/10.1111/hae.14212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898816/
https://www.ncbi.nlm.nih.gov/pubmed/33245841
http://dx.doi.org/10.1111/hae.14212

Ejemplares similares